The U.S. Food and Drug Administration is delaying until March 19, 2018, its final rule for clarification of when products made or derived from tobacco are regulated as drugs, devices, or combination products under the Federal Food, Drug, and Cosmetic Act.
The agency wants to seek public feedback on issues raised by a petition from affected parties that asks for clarification on the amendments to the regulations regarding “intended uses.”
The delay will also provide additional time to the FDA to fully evaluate the comments.